Zhou JH - Search Results

1

The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-κB activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells.

Huang K, Yang C, Wang QX, Li YS, Fang C, Tan YL, Wei JW, Wang YF, Li X, Zhou JH, Zhou BC, Yi KK, Zhang KL, Li J, Kang CS. Huang K, et al. Among authors: zhou jh, zhou bc. Cancer Lett. 2017 Mar 1;388:269-280. doi: 10.1016/j.canlet.2016.12.011. Epub 2016 Dec 18. Cancer Lett. 2017. PMID: 27998759

2

A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.

Wang Q, Zhang J, Liu Y, Zhang W, Zhou J, Duan R, Pu P, Kang C, Han L. Wang Q, et al. Cancer Lett. 2016 Apr 10;373(2):251-9. doi: 10.1016/j.canlet.2016.01.039. Epub 2016 Jan 29. Cancer Lett. 2016. PMID: 26828136

3

EGFR/EGFRvIII remodels the cytoskeleton via epigenetic silencing of AJAP1 in glioma cells.

Yang C, Li YS, Wang QX, Huang K, Wei JW, Wang YF, Zhou JH, Yi KK, Zhang KL, Zhou BC, Liu C, Zeng L, Kang CS. Yang C, et al. Among authors: zhou jh, zhou bc. Cancer Lett. 2017 Sep 10;403:119-127. doi: 10.1016/j.canlet.2017.06.007. Epub 2017 Jun 17. Cancer Lett. 2017. PMID: 28634045

4

Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2.

Chen Q, Cai J, Wang Q, Wang Y, Liu M, Yang J, Zhou J, Kang C, Li M, Jiang C. Chen Q, et al. Clin Cancer Res. 2018 Feb 1;24(3):684-695. doi: 10.1158/1078-0432.CCR-17-0605. Epub 2017 Nov 14. Clin Cancer Res. 2018. PMID: 29138341

5

The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.

Huang K, Fang C, Yi K, Liu X, Qi H, Tan Y, Zhou J, Li Y, Liu M, Zhang Y, Yang J, Zhang J, Li M, Kang C. Huang K, et al. Theranostics. 2018 Feb 7;8(6):1540-1557. doi: 10.7150/thno.22952. eCollection 2018. Theranostics. 2018. PMID: 29556340 Free PMC article.

6

Effects of combined radiosurgery and temozolomide therapy on epidermal growth factor receptor and variant III in glioblastoma multiforme.

Lin Y, Zhou J, Xu J, Zhao K, Liu X, Wang G, Zhang Z, Ge Y, Zong Y, Xu D, Tan Y, Fang C, Kang C. Lin Y, et al. Oncol Lett. 2018 Apr;15(4):5751-5759. doi: 10.3892/ol.2018.8055. Epub 2018 Feb 14. Oncol Lett. 2018. PMID: 29563997 Free PMC article.

7

Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway.

Wang Q, Cai J, Fang C, Yang C, Zhou J, Tan Y, Wang Y, Li Y, Meng X, Zhao K, Yi K, Zhang S, Zhang J, Jiang C, Zhang J, Kang C. Wang Q, et al. Theranostics. 2018 Sep 9;8(17):4733-4749. doi: 10.7150/thno.26550. eCollection 2018. Theranostics. 2018. PMID: 30279734 Free PMC article.

8

PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma.

Zhang Z, Wang Z, Huang K, Liu Y, Wei C, Zhou J, Zhang W, Wang Q, Liang H, Zhang A, Wang G, Zhen Y, Han L. Zhang Z, et al. Cancer Lett. 2019 Feb 28;443:91-107. doi: 10.1016/j.canlet.2018.11.034. Epub 2018 Dec 4. Cancer Lett. 2019. PMID: 30529153

9

Systemic Delivery of Monoclonal Antibodies to the Central Nervous System for Brain Tumor Therapy.

Han L, Liu C, Qi H, Zhou J, Wen J, Wu D, Xu D, Qin M, Ren J, Wang Q, Long L, Liu Y, Chen I, Yuan X, Lu Y, Kang C. Han L, et al. Adv Mater. 2019 May;31(19):e1805697. doi: 10.1002/adma.201805697. Epub 2019 Feb 17. Adv Mater. 2019. PMID: 30773720

10

Identification of long non-coding RNA HERC2P2 as a tumor suppressor in glioma.

Yang C, Wang L, Sun J, Zhou JH, Tan YL, Wang YF, You H, Wang QX, Kang CS. Yang C, et al. Among authors: zhou jh. Carcinogenesis. 2019 Aug 22;40(8):956-964. doi: 10.1093/carcin/bgz043. Carcinogenesis. 2019. PMID: 30809632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

973 results

Search Page

Filters